Observationa Study is a Prospective and Multi-institutional Observational Study.

This observational study is a prospective, multi-institutional non intervention study to examine the prescription patterns, corresponding treatment effects and safety in routine clinical practice for patients prescribed for the treatment of gastroesophageal reflux disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Erosive Reflux Disease Acid Regurgitation Deglutition Disorders Digestive System Diseases Esophageal Diseases Esophageal Motility Disorders Gastroesophageal Reflux Gastrointestinal Diseases Heartburn Pathological Conditions, Signs and Symptoms Signs and Symptoms Signs and Symptoms, Digestive

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Goodbreath Medical Center

Seoul, Gyeonggi-do, 15865, South Korea

About this study

The present observational study is designed to check effect and safety for patients who have been prescribed JAQBO for the treatment of erosive gastroesophageal reflux disease.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

An adult over 19 years of age
A person who voluntarily provides written informed consent

Exclusion criteria

A pregnant woman or a nursing woman
A person who is deemed unsuitable for the subject of the study

Treatment and study plan

Primary outcomes

Change in GERD (heartburn, acid regurgitation) score in RDQ

Time frame: 4 weeks

Scale(none / 1day / 2day/ 3-4 day / 5-6 day/ every day)

Sponsors and collaborators

Lead sponsor

Jeil Pharmaceutical Co., Ltd.

Industry

Registry information

Official study title

Observational Study to Evaluate Effectiveness, Safety and Satisfaction Level of Zastaprazan (JAQBO®) Under Daily Treatment for Patients With Erosive Gastroesophageal Reflux Disease

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: May 1, 2025
Registry last updated: May 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed